Loading organizations...
§ Private Profile · Tallinn, Harjumaa, Estonia
Biotech company producing bio-based nanofibers as 3D scaffolds for cell culture, tissue engineering, and cultured meat.
Based in Tallinn, Estonia, Gelatex Technologies manufactures bio-based nanofibers at scale using proprietary halospinning technology to create 3D scaffolds for cell culture, tissue engineering, and cultured meat production. The organization initially focused on developing leather-like textiles before executing a strategic pivot in 2020 to supply advanced nanomaterials to the medical, pharmaceutical, and cellular agriculture sectors. Alongside direct material sales for applications in toxicology, stem cell research, and drug discovery, the firm licenses its patented manufacturing processes to industrial partners. Gelatex Technologies previously participated in The Heritage Group Accelerator powered by Techstars, securing a $120,000 initial investment to expand its operational footprint. In 2024, the enterprise opened a €15 million Series A funding round to establish a food-safety compliant pilot production facility. Gelatex Technologies was founded in 2016 by Mari-Ann Meigo Fonseca and Märt-Erik Martens.
Gelatex Technologies has raised $1.4M across 1 funding round.
Gelatex Technologies has raised $1.4M in total across 1 funding round.
Gelatex Technologies has raised $1.4M across 1 funding round. Most recently, it raised $1.4M Seed in November 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 27, 2021 | $1.4M Seed | Change Ventures, Crosslight Partners | — | Announced |
Gelatex Technologies has raised $1.4M in total across 1 funding round.
Gelatex Technologies's investors include Change Ventures, Crosslight Partners.